Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muh Geot Wong

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
The Lancet. Diabetes & Endocrinology|August 2, 2016
Knowing what we do not know: statin therapy in advanced chronic kidney diseaseMuh Geot Wong, Vlado Perkovic
Nephrology (Carlton, Vic.)|January 18, 2024
Haematuria in immunoglobulin a nephropathy: To be or not to be?Jessica Sun, Muh Geot Wong
Kidney & Blood Pressure Research|March 27, 2023
Corticosteroid Therapy in Immunoglobulin A Nephropathy: A Friend or Foe?Dana Kim, Muh Geot Wong
Lancet (London, England)|June 4, 2026
Endothelin antagonism in IgA nephropathy: promise ahead of proof?Peter-Joon Lee, Muh Geot Wong
Kidney International Supplements|August 28, 2015
Biomarkers in kidney fibrosis: are they useful?Muh Geot Wong, Carol A Pollock
Nephrology (Carlton, Vic.)|September 27, 2024
The role of endothelin receptor antagonists in IgA nephropathyMitchell Hunter-Dickson, Muh Geot Wong
The Lancet. Diabetes & Endocrinology|October 8, 2018
Glucose lowering and the kidney: are all drug classes equal?Muh Geot Wong, Meg Jardine, Vlado Perkovic
The Lancet. Diabetes & Endocrinology|January 18, 2016
ALTITUDE: defining a ceiling for blockade of the renin-angiotensin system?Martin Gallagher, Muh Geot Wong, Vlado Perkovic
JAMA|September 20, 2022
Oral Methylprednisolone and Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy-ReplyMuh Geot Wong, Jicheng Lv, Vlado Perkovic
BMJ Case Reports|July 28, 2021
Anti-glomerular basement membrane disease and IgA nephropathy in a patient with previous renal cell carcinomaCandice Khor, Muh Geot Wong, Jessica Reagh
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
The Lancet. Diabetes & Endocrinology|August 2, 2016
Knowing what we do not know: statin therapy in advanced chronic kidney diseaseMuh Geot Wong, Vlado Perkovic
Nephrology (Carlton, Vic.)|January 18, 2024
Haematuria in immunoglobulin a nephropathy: To be or not to be?Jessica Sun, Muh Geot Wong
Kidney & Blood Pressure Research|March 27, 2023
Corticosteroid Therapy in Immunoglobulin A Nephropathy: A Friend or Foe?Dana Kim, Muh Geot Wong
Lancet (London, England)|June 4, 2026
Endothelin antagonism in IgA nephropathy: promise ahead of proof?Peter-Joon Lee, Muh Geot Wong
Kidney International Supplements|August 28, 2015
Biomarkers in kidney fibrosis: are they useful?Muh Geot Wong, Carol A Pollock
Nephrology (Carlton, Vic.)|September 27, 2024
The role of endothelin receptor antagonists in IgA nephropathyMitchell Hunter-Dickson, Muh Geot Wong
The Lancet. Diabetes & Endocrinology|October 8, 2018
Glucose lowering and the kidney: are all drug classes equal?Muh Geot Wong, Meg Jardine, Vlado Perkovic
The Lancet. Diabetes & Endocrinology|January 18, 2016
ALTITUDE: defining a ceiling for blockade of the renin-angiotensin system?Martin Gallagher, Muh Geot Wong, Vlado Perkovic
JAMA|September 20, 2022
Oral Methylprednisolone and Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy-ReplyMuh Geot Wong, Jicheng Lv, Vlado Perkovic
BMJ Case Reports|July 28, 2021
Anti-glomerular basement membrane disease and IgA nephropathy in a patient with previous renal cell carcinomaCandice Khor, Muh Geot Wong, Jessica Reagh
Pageof 9